Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 9 results found. Search for [ Russia to supply 100 million doses of Sputnik V vaccine in India ]

Results 1 to 9 of 9
BusinessToday.In
September 18, 2020
Kirill Dmitriev, CEO of Russia's sovereign wealth fund Russian Direct Investment Fund, says India will play a vital role in fighting Covid-19 and that government's Make in India initiative has made pharma sector stronger


BusinessToday.In
September 17, 2020
As part of the settlement, Celgene has agreed to provide Dr Reddy's with a licence to sell volume-limited amounts of generic lenalidomide capsules in the US after March 2022 subject to regulatory approval


BusinessToday.In
September 17, 2020
Dr Reddy's Laboratories stock which closed 4.24% higher in the previous session gained 4.21% or Rs 195 to close at Rs 4,826 on BSE today


BusinessToday.In
New Delhi, September 17, 2020
COVID-19 vaccine from Russia! Dr Reddy's ties up with a Russian firm for 100 million dosesHyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Sputnik V vaccine is undergoing final stage clinical trials in Russia. It is also being tested in several other countries. \"Deliveries could potentially...


Joe C Mathew
September 16, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, a joint statement issued by RDIF and Dr Reddy's says


BusinessToday.In
September 16, 2020
Dr Reddy's Lab share touched an intraday high of Rs 4651.95, a rise of 4.7% on BSE


Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year


PB Jayakumar
August 14, 2020
The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers


PAGES 1 OF 1